Delivery Order SPE2DB20D1004-SPE2DB23FG4N1

Award Date 8/28/23
Potential Completion Date 8/29/23
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,279.01 firm fixed price delivery order is for the supply of Carafate 1 GM/10 ML suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an indefinite...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Carafate 1 GM/10 ML Suspension in 420 ML bottles. The contract has a ceiling value of $3,983.93 and a completion date of July 19, 2023. The contract is a firm fixed-price type without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
This federal contract award, identified as SPE2DX15D3020|SPE2DX24FXJZF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of Carafate 1 gram tablets. The contract has a ceiling value of $12,768.88 and a completion date of December 22, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major pharmaceutical...
This federal contract award, with an ID of SPE2DX15D2101|SPE2DX24F51RM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,418.39 firm fixed-price delivery order is for the supply of Carafate 1 gm/10 ml suspension, a gastrointestinal medication, to support military healthcare programs. The contract has an ultimate completion date of May 2, 2024 and was awarded on...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,246.16 firm fixed-price delivery order is for the supply of 420 milliliters of Sucralfate 1 gram per 10 milliliters suspension to support federal healthcare programs. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,974.12 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a $5,351.43 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sucralfate 1 GM/10 ML Suspension. This contract has an ultimate completion date of November 8, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sucralfate 1 gm/10 ml suspension. The $4,597.18 firm fixed price contract has a completion date of June 23, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.00 fixed-price delivery order contract is for the supply of sucralfate 1 gram/10 milliliter suspension in 420 milliliter bottles. The contract has an ultimate completion date of December 3, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sucralfate 1 GM/10 ML Suspension (420 ML). The $1,096.26 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG4N1
    Delivery Order

This federal contract award is for the delivery of Carafate 1 GM/10 ML suspension in 420 ML units from Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the Defense Logistics Agency (DLA). The $1,895.88 firm fixed-price delivery order contract has an ultimate completion date of August 29, 2023.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, and medical devices, to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:49 AM